Home » Topics » Regulatory

Regulatory
RSS

Licensing activity update for Zindaclin

March 17, 2003

Low-dose Prempro approved by FDA

March 17, 2003

Levitra approved in E.U.

March 11, 2003

New indication for Arava recommended for approval

March 10, 2003

Lercanidipine 20 mg approved in Europe

March 7, 2003

Oral tazarotene completes phase III studies

March 7, 2003

Myoview approved for assessment of left ventricular function

March 6, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

March 6, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...